Baxter International ( (BAX) ) has issued an update.
In March 2025, Baxter International announced significant leadership changes, with Brent Shafer appointed as Chair and Interim CEO, and Heather Knight as COO and Interim Group President of Medical Products & Therapies. The company completed its strategic initiatives from January 2023, including the divestiture of its Kidney Care segment, and implemented a redesigned operating model to enhance accountability and support accelerated growth. An Operating Committee of independent directors was also established to oversee product development and operational efficiency improvements.
More about Baxter International
Baxter International Inc. is a leading global medical technology company focused on providing medically essential products and transformative innovations. The company is dedicated to advancing its mission to save and sustain lives, with a focus on strategic growth and improved profitability.
YTD Price Performance: 19.06%
Average Trading Volume: 5,013,829
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $17.61B
For detailed information about BAX stock, go to TipRanks’ Stock Analysis page.